Dr. John Allen Vanwagoner , MD
Specialist • Plano, TX
6101 Windcom Ct, Suite 400
Plano, TX 750937817
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 10, 2006; this date does not establish years in practice.
-
Published CMS data list 15,034 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2357 — Injection, omalizumab, 5 mg: 4,785 service units.
- 95004 — Test for allergy using allergenic extract: 4,313 service units.
- 95165 — Professional service for preparation and provision of 1 or more antigens: 3,014 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 20 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 536 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Montelukast Sodium — 60 prescription fills, including refills.
- Ipratropium Bromide — 53 prescription fills, including refills.
- Prednisone — 42 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Specialist in Plano, TX (2024, 11 clinicians with data). Median for this group: 1,459. Middle half: 276 to 2,963.
More Medicare Part B services than 95% of clinicians listed under Specialist in Texas (2024, 311 clinicians with data). Median for this group: 1,062. Middle half: 330 to 2,605.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 15,292 in 2020 to 15,034 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
6101 Windcom Ct
Suite 400
Plano, TX 750937817
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: John Allen Van Wagoner, Md, Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Southwestern Medical School At Dallas
1996
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
472 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $364,009 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $269,626 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
679 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$565,447 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,766.86 across 111 records.
By nature of payment
- Food and Beverage: $2,621.00 across 107 records.
- Education: $80.27 across 2 records.
- Consulting Fee: $65.59 across 2 records.
Reporting-company totals (3 largest of 22)
- AstraZeneca Pharmaceuticals LP: $425.81 across 15 records.
- Regeneron Pharmaceuticals, Inc.: $329.56 across 17 records.
- GlaxoSmithKline, LLC.: $325.19 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
30 years (graduated 1996)
CMS Doctors and Clinicians data list 1996 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Vanwagoner has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Vanwagoner as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Plano and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Specialist in Plano, TX (2024, 11 clinicians with data). Median for this group: 1,459. Middle half: 276 to 2,963.
More Medicare Part B services than 95% of clinicians listed under Specialist in Texas (2024, 311 clinicians with data). Median for this group: 1,062. Middle half: 330 to 2,605.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Specialist in Plano, TX (2024, 11 clinicians with data). Median for this group: $115,524. Middle half: $20,135 to $174,617.
A higher Medicare-allowed amount than 85% of clinicians listed under Specialist in Texas (2024, 311 clinicians with data). Median for this group: $94,246. Middle half: $29,082 to $195,266.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Specialist in Plano, TX (2024, 11 clinicians with data). Median for this group: $79,704. Middle half: $15,407 to $126,009.
A higher Medicare payment amount than 85% of clinicians listed under Specialist in Texas (2024, 311 clinicians with data). Median for this group: $70,066. Middle half: $20,634 to $143,082.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Specialist in Plano, TX (2024, 16 clinicians with data). Median for this group: 167. Middle half: 46 to 463.
Close to the middle for clinicians listed under Specialist in Texas (2024, 367 clinicians with data). Median for this group: 458. Middle half: 89 to 1,434.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in Plano, TX (2024, 16 clinicians with data). Median for this group: $2,899. Middle half: $1,467 to $30,931.
A higher Part D drug cost than 85% of clinicians listed under Specialist in Texas (2024, 367 clinicians with data). Median for this group: $19,718. Middle half: $1,229 to $181,992.
55 active clinicians are listed under Specialist with a practice address in Plano, TX (1,729 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Plano
5.5% of these 55 clinicians have the CMS telehealth indicator.
12.7% of these 55 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 15,292 in 2020 and 15,034 in 2024.
- 2020: 15,292
- 2021: 15,628
- 2022: 15,965
- 2023: 12,400
- 2024: 15,034
-
Medicare-allowed amount
Medicare-allowed amount increased 55% from $235,416 in 2020 to $364,009 in 2024.
- 2020: $235,416
- 2021: $272,596
- 2022: $278,391
- 2023: $217,777
- 2024: $364,009
-
Paid by Medicare
Paid by Medicare increased 54% from $174,894 in 2020 to $269,626 in 2024.
- 2020: $174,894
- 2021: $201,876
- 2022: $208,328
- 2023: $159,172
- 2024: $269,626
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 565 in 2020 and 536 in 2024.
- 2020: 565
- 2021: 331
- 2022: 388
- 2023: 432
- 2024: 536
-
30-day fills
30-day fills varied from year to year: 660 in 2020 and 679 in 2024.
- 2020: 660
- 2021: 412
- 2022: 452
- 2023: 568
- 2024: 679
-
Part D drug cost
Part D drug cost increased 18% from $478,972 in 2020 to $565,447 in 2024.
- 2020: $478,972
- 2021: $461,739
- 2022: $680,626
- 2023: $567,748
- 2024: $565,447
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $389.54 in 2021 to $2,766.86 in 2025.
- 2021: $389.54
- 2022: $496.95
- 2023: $159.80
- 2024: $347.52
- 2025: $2,766.86
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 111 records totaling $2,766.86.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $143.64 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $124.98 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $121.82 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $121.19 |
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
EBGLYSS | General | $110.13 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $102.93 |
| Regeneron Pharmaceuticals, Inc. |
Education
In-kind items and services
|
DUPIXENT | General | $73.50 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $36.90 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $36.41 |
| ADMA BioManufacturing LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $34.00 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $33.34 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $32.81 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
EOHILIA | General | $32.44 |
| ADMA BioManufacturing LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $31.59 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $31.42 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $30.26 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.57 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Rhapsido | General | $29.38 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $29.37 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $28.98 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $28.48 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
— | General | $28.25 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $27.85 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $27.74 |
| Blueprint Medicines Corporation |
Food and Beverage
Cash or cash equivalent
|
AYVAKIT | General | $26.65 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2357
Injection, omalizumab, 5 mg
|
4,785 | 11 | $75.00 | $37.53 |
|
95004
Test for allergy using allergenic extract
|
4,313 | 81 | $10.00 | $3.18 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
3,014 | 71 | $24.65 | $12.74 |
|
95117
Professional service for multiple injections of allergen
|
853 | 70 | $35.00 | $10.71 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
524 | 319 | $130.00 | $113.89 |
|
95115
Professional service for single injection of allergen
|
245 | 27 | $25.00 | $9.00 |
|
95024
Test for allergy using allergenic extract injected into skin
|
220 | 13 | $12.00 | $6.50 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
208 | 170 | $20.00 | $14.62 |
|
94375
Test to measure rate of airflow
|
194 | 133 | $60.00 | $34.37 |
|
96401
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
|
183 | 14 | $150.00 | $61.85 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
137 | 137 | $195.00 | $148.05 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
112 | 100 | $95.00 | $80.13 |
|
95012
Test to measure the level of nitric oxide gas
|
88 | 71 | $35.00 | $16.40 |
|
70486
Ct scan of face without contrast
|
38 | 35 | $248.68 | $109.79 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
29 | 29 | $85.00 | $34.24 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
24 | 24 | $135.00 | $100.23 |
|
96372
Injection of drug or substance under skin or into muscle
|
23 | 14 | $40.00 | $12.78 |
|
J7613
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
|
18 | 18 | $1.00 | $0.05 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
13 | 12 | $50.77 | $20.58 |
|
J7644
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
|
13 | 13 | $10.00 | $0.32 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Montelukast Sodium | Montelukast Sodium | 60 | 3,423 | $361.11 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 53 | 1,725 | $1,424.72 | 24 |
| Prednisone | Prednisone | 42 | 357 | $80.61 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 794 | $1,071.54 | 25 |
| Hizentra | Immun Glob G(Igg)/Pro/Iga 0-50 | 28 | 702 | $230,671.43 | — |
| Dupixent Syringe | Dupilumab | 27 | 756 | $100,587.81 | — |
| Epinephrine | Epinephrine | 26 | 612 | $6,001.37 | 26 |
| Hyqvia | Igg/Hyaluronidase,recombinant | 26 | 728 | $84,644.85 | — |
| Azelastine Hcl | Azelastine Hcl | 25 | 1,120 | $675.08 | — |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | 780 | $9,458.96 | — |
| Azithromycin | Azithromycin | 23 | 725 | $114.24 | 12 |
| Cefdinir | Cefdinir | 21 | 321 | $423.20 | 16 |
| Gamunex-C | Immune Globul G/Gly/Iga Avg 46 | 20 | 560 | $62,847.94 | — |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | 1,200 | $23,654.87 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 209 | $208.51 | 18 |
| Amoxicillin | Amoxicillin | 17 | 545 | $49.91 | — |
| Fluticasone Propionate | Fluticasone Propionate | 17 | 900 | $253.50 | — |
| Levofloxacin | Levofloxacin | 13 | 128 | $53.52 | — |
| Omeprazole | Omeprazole | 13 | 510 | $42.76 | — |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | 510 | $1,658.99 | — |
| Dupixent Pen | Dupilumab | 11 | 294 | $41,162.21 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-04-15NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20100813000139
TX
9133253198
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
John Allen Van Wagoner, Md, Pa
5012 S Us Hwy 75, Denison, TX 750204594
Phone: 9034638400
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Allergy & Immunology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant
Physician Assistant
Physician Assistant
Physician Assistant (Certified)
Nurse Practitioner
Family Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 6101 WINDCOM CT STE 400, PLANO, TX 750937820 (Tel: 9723983500)
NPI status registered as active in NPPES database
Registered at 6101 WINDCOM CT, SUITE 400, PLANO, TX 750937817 (Tel: 9723983500)
Registered at 6101 WINDCOM CT, SUITE 400, PLANO, TX 750937817 (Tel: 9723983500)
Recorded as JOHN VANWAGONER, M.D.
Specialist (license number reported to NPPES: TX K8854)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Specialists in Plano
- Dr. Richard Bowman, MD
- Dr. Aaron Bransky, MD
- Dr. Edward Shin, MD
- Dr. Hong Davis, MD
- Dr. Jeffrey Caruth, MD
- Dr. Natan Yaker, MD
More public profiles in Texas
Directory navigation, in NPI number order.
- Nick Aguilar, MD Family Medicine · San Antonio
- Sudheer Jayaprabhu, MD Obstetrics & Gynecology · Texarkana
- Larry Molenda, DDS Dentist - General Practice · San Marcos
- Adrian Meyer, MD Internal Medicine · Richardson
- Tamsak Kanoklukul, CRNA Nurse Anesthetist, Certified Registered · Waco
- Anna Alquiza, MD Internal Medicine · Houston
- Michael Borchers, DDS Dentist - General Practice · Kerrville
- Pedro Diaz Santana, MD Internal Medicine - Interventional Cardiology · Laredo
- Carylon Frerich, PA Physician Assistant · Big Spring
- Anthony Thompson, DO Family Medicine · Kingsville
- Martin Sloan, DPM Podiatrist · Abilene
- Satbir Risam, MD Internal Medicine · Addison
Mailing Address
6101 Windcom Ct Ste 400
Plano, TX 750937820
Phone: 9723983500